⚠ Utilisation Falls When the Procedures Do Not HappenHigh threat
Intuitive Surgical (ISRG) — threat to the moat
Placements are running ahead of volume growth, which is right only if the slowdown is temporary.
Utilisation is a ratio, and the numerator is procedures. Everything that reduces procedure volume reduces it, regardless of how good the installed base is.
2026 supplied the demonstration. United States da Vinci procedure growth fell from 14% in the first quarter to 12% in the second, concentrated in deferrable benign categories, with management citing changes in patient coverage following the expiry of enhanced Affordable Care Act premium subsidies1. Utilisation still rose 3% in the quarter, but that is because the base grew more slowly than procedures did — a gap that closes fast if procedure growth keeps decelerating while placements continue.
The arithmetic is worth stating. If the installed base grows 12% and procedures grow 12%, utilisation is flat. If procedures grow 10% while the base grows 12%, utilisation falls — and the recurring revenue per system with it. Intuitive placed 468 systems in the June 2026 quarter, up 18%2, into a market where procedure growth was 15% and decelerating.
That is the tension in the current strategy: placements are running ahead of volume growth, which is right if the volume slowdown is temporary and wrong if it is not.
Put the two series side by side. Procedure growth below installed-base growth for a full year would turn utilisation negative, and utilisation is the number that determines whether the newest cohort of systems ever pays for itself.
- ReportedUnited States da Vinci procedure growth fell from 14% in the first quarter to 12% in the second, concentrated in deferrable benign categories, with management citing changes in patient coverage following the expiry of enhanced Affordable...Intuitive Surgical Q2 2026 earnings call - the Extended Use Program raising permitted uses on selected EndoWrist instruments from the first half of 2027, US da Vinci procedure growth of 12% against 14% attributed to the expiry of enhanced Affordable Care Act premium subsidies, full-year guidance of 13.5% to 15.5% nearer the midpoint, gross-margin guidance raised to 68-69%, and Japanese placements of 25 against 15 — Q2 2026 · publ. July 16, 2026 · source ↗
- ReportedIntuitive placed 468 systems in the June 2026 quarter, up 18%, into a market where procedure growth was 15% and decelerating.Intuitive Surgical Form 10-Q, quarter ended June 30, 2026 (installed base 11,710 da Vinci systems up 12%, 468 placements of which 246 were da Vinci 5, the operating-lease share, the distributor acquisitions in Italy, Spain and Portugal, cash and investments of $8.63 billion, and the factors expected to affect future placements) — Q2 2026 and the first six months · publ. July 21, 2026 · source ↗